The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma

Published:2020-01 Issue: Volume:51 Page:102610
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Xia Shunjie,Pan Yu,Liang Yuelong,Xu Junjie,Cai Xiujun

Funder

National Natural Science Foundation of China

Zhejiang Provincial Natural Science Foundation of China

Zhejiang University

Hubei Chen Xiaoping Science and Technology Development Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference90 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol,2009

3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma;Xu;Ann Oncol,2019

5. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance;Xiang;Gut,2019

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer;Current Pharmaceutical Design;2024-10

2. A quartet of cancer stem cell niches in hepatocellular carcinoma;Cytokine & Growth Factor Reviews;2024-10

3. Sorafenib, a Tyrosine Kinase Inhibitor, Synergistically Enhances the Ferroptosis Effects of Asiatic Acid in Hepatocellular Carcinoma Cells;Environmental Toxicology;2024-09-12

4. Discovery of SILA-123 as a Highly Potent FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia with Various FLT3 Mutations;Journal of Medicinal Chemistry;2024-09-11

5. Sorafenib-mediated cleavage of p62 initiates cellular senescence as a mechanism to evade its anti-hepatocellular carcinoma efficacy;Oncogene;2024-09-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3